Submitted by Anonymous (not verified) on 24 June 2025 - 14:45
Human medicines European public assessment report (EPAR): Perjeta, pertuzumab, Date of authorisation: 04/03/2013, Revision: 25, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Perjeta, pertuzumab, Date of authorisation: 04/03/2013, Revision: 25, Status: Authorised